BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15383796)

  • 1. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.
    Eilber FC; Eilber FR; Eckardt J; Rosen G; Riedel E; Maki RG; Brennan MF; Singer S
    Ann Surg; 2004 Oct; 240(4):686-95; discussion 695-7. PubMed ID: 15383796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.
    Eilber FC; Brennan MF; Eilber FR; Eckardt JJ; Grobmyer SR; Riedel E; Forscher C; Maki RG; Singer S
    Ann Surg; 2007 Jul; 246(1):105-13. PubMed ID: 17592298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
    Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
    Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.
    Chen Y; Yang Y; Wang C; Shi Y
    J Surg Oncol; 2012 Aug; 106(2):162-8. PubMed ID: 22297839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
    Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
    Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.
    Rutkowski P; Trepka S; Ptaszynski K; Kołodziejczyk M
    Clin Orthop Relat Res; 2013 Mar; 471(3):860-70. PubMed ID: 22972658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposarcoma in adult limbs treated by limb-sparing surgery and adjuvant radiotherapy.
    Issakov J; Soyfer V; Kollender Y; Bickels J; Meller I; Merimsky O
    J Bone Joint Surg Br; 2006 Dec; 88(12):1647-51. PubMed ID: 17159180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
    Wang B; Yu X; Xu S; Xu M
    Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.
    Grobmyer SR; Maki RG; Demetri GD; Mazumdar M; Riedel E; Brennan MF; Singer S
    Ann Oncol; 2004 Nov; 15(11):1667-72. PubMed ID: 15520069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
    Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
    Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
    Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid liposarcoma. Experience with chemotherapy.
    Patel SR; Burgess MA; Plager C; Papadopoulos NE; Linke KA; Benjamin RS
    Cancer; 1994 Aug; 74(4):1265-9. PubMed ID: 8055448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
    Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
    Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
    Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center.
    Yilmaz U; Kamer S; Kaya H; Sabah D; Sanli UA; Tamsel I; Yaman B; Akalin T; Anacak Y
    Strahlenther Onkol; 2023 Jun; 199(6):585-594. PubMed ID: 36725697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
    Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
    Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.